Related Experiment Videos
Systemic treatment in advanced melanoma: innovative perspectives
1Klinische Kooperationseinheit Dermato-Onkologie, Deutsches Krebsforschungszentrum Heidelberg/Universitäts-Hautklinik Mannheim, Germany. s.ugurel@dkfz.de
Onkologie
|July 8, 2003
Summary
Malignant melanoma with distant metastases has a poor prognosis. Innovative therapies, including chemosensitivity testing and advanced vaccination strategies, are being investigated to improve patient survival and overcome treatment resistance.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Malignant melanoma incidence is rising.
- Early-stage melanoma offers a high cure rate after surgery.
- Advanced melanoma with metastases has a poor prognosis despite various treatments.
Purpose of the Study:
- To review innovative therapeutic strategies for malignant melanoma.
- To highlight treatments currently in clinical trials.
- To address challenges in melanoma therapy resistance.
Main Methods:
- Review of clinical trials for advanced melanoma treatments.
- Focus on pretherapeutic chemosensitivity testing.
- Exploration of bcl-2 downregulation for chemosensitization.
- Evaluation of dendritic cell vaccination and histamine immunomodulation.
Main Results:
- Conventional cytotoxic treatments and cytokine combinations show limited efficacy in improving overall survival.
- Research is actively elucidating mechanisms of melanoma therapy resistance.
- New treatment concepts are emerging to overcome resistance.
Conclusions:
- Standard therapies offer only temporary responses for metastatic melanoma.
- Innovative strategies like targeted chemosensitization and advanced immunotherapies show promise.
- Further clinical investigation is crucial for developing effective melanoma treatments.